Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-09-040003
Filing Date
2009-08-11
Accepted
2009-08-11 17:13:46
Documents
2
Period of Report
2009-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 20313
2 EX-24 DOCUMENT attachment1.htm EX-24.3_296745 185
  Complete submission text file 0001209191-09-040003.txt   22219
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 422 WILLIAM WALLACE DRIVE FRANKLIN TN 37064
Business Address
Lowrance David L (Reporting) CIK: 0001408498 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 091004555